June 17, 2022|Access to Medicines, COVID-19Statement from Asia Russell, Health GAP Executive Director, on the Failure of the WTO’s MC12 to Deliver a TRIPS Waiver for COVID-19 Vaccines, Treatments, and Tests“The World Trade Organization’s 12th Ministerial Conference (MC12) was a dismal failure for the 85% of people in low-income countries that have not had a single dose of COVID-19 vaccine, for the billions of people worldwide without access to COVID-19…
May 4, 2022|Access to MedicinesCampaigners protest GSK for pricing game-changing HIV prevention medication 100 times more expensive than gold, blocking global accessCampaigners unfurl banner outside GlaxoSmithKline Annual General Meeting demanding subsidiary ViiV Healthcare sell new injectable at a price comparable to generic oral prevention pills, and immediately commit to sharing technology with generic manufacturers As GSK shareholders gather in person at…
April 20, 2022|Access to Medicines, COVID-19109 Civil Society Organizations Call on Dominican Republic President Luis Abinader to Support Compulsory License to Expand Access and Break Pfizer’s Monopoly Over Lifesaving COVID-19 TreatmentDecision Expected Any Day in Landmark Case Filed by KEI Could Set Precedent Across Low- and Middle-Income Countries, Determine Trajectory of Access to Essential COVID-19 Treatments Pfizer Brazenly Claimed its “Human Rights” in Pushback Against Effort to Utilize Existing Public…
April 4, 2022|Access to MedicinesLong-Acting PreP is a Necessity, Not a Luxury: ViiV’s Greed is Still Blocking Global Access to Injection that Could Transform HIV Prevention and Help End the Pandemic In response to ViiV’s announcement today that it is working with the Medicines Patent Pool “to outline a positive path forward for voluntary licensing of long-acting HIV prevention,” Health GAP released the following statement: “ViiV's statement today with the Medicines…
March 17, 2022|Access to Medicines, COVID-19Nearly 100 Health, Development and Human Rights Groups Write Pfizer CEO Demanding Immediate Action to Increase Access to COVID-19 Antivirals in Low- and Middle-Income CountriesPfizer COVID-19 Treatment Licensing Deal with Medicines Patent Pool Excludes Almost 50% of the Globe Perpetuating Medical Apartheid Nearly 100 health, development, and human rights organizations sent a letter today to Pfizer CEO Albert Bourla demanding immediate steps to increase access to COVID-19…
November 17, 2021|Access to Medicines, COVID-19Statement on the Biden Administration Plan to Increase COVID-19 Vaccine Manufacturing CapacityAsia Russell, Health GAP Executive Director, said: “This is a dire global health emergency, and instead of using their power to compel pharma companies to share know-how to build capacity and rapidly expand vaccine manufacturing around the world, the Biden…
October 21, 2021|Access to MedicinesOn Pfizer CEO Albert Bourla’s Birthday, Medical Students and Activists from Health GAP, Rise and Resist, CPD Action and More Protest at His Home to Demand Equitable Global Access to COVID-19 VaccinesScarsdale, NY, October 21, 2021 (Globe Newswire) – On Pfizer CEO Albert Bourla’s birthday, medical students and activists held a mock celebration by placing a faux “Pfizer graveyard” outside Bourla’s home to denounce his role in blocking access to life-saving…
July 21, 2021|Access to Medicines, COVID-19Pfizer-BioNTech Fill and Finish Deal with Biovac in South Africa Is the Latest Step in Pharma’s Campaign to Convince the World the Status Quo is Good EnoughStatement from Brook Baker, Senior Policy Analyst, Health GAP, regarding the COVID-19 vaccine agreement announced today between Pfizer, BioNTech, and Biovac: “This is a far cry from actual technology transfer to allow independent manufacture of mRNA vaccines and therapeutics in…
June 3, 2021|Access to Medicines, COVID-19March & Vigil Calling for Global Access to COVID-19 Vaccines Held at Western Countries’ UN Missions in New York City Free the Vaccine Activists Remember Those Around the World Lost to COVID-19, and Called for Rich Nations to #EndVaccineApartheid via WTO TRIPS Waiver (New York, NY) — Dozens of New York activists gathered this evening outside Pfizer World Headquarters…
May 5, 2021|Access to Medicines, COVID-19Statement in Response to USTR Announcement that the U.S. Will Support Waiving Intellectual Property Protections for COVID-19 VaccinesHealth GAP Executive Director Asia Russell said: “As HIV activists, we know that activism and global solidarity can change the trajectory of a pandemic. Today’s announcement shows that the Biden administration is feeling the pressure built over many months of…
